Document is current
Any future updates will be listed below
-
Authors
Geissler, Mark Enrik
Bereuter, Jean-Paul
Geissler, Rona Berit
Kowalewski, Karl-Friedrich
Egen, Luisa
Haney, Caelan
Schmidt, Sofia
Fries, Alexa
Buck, Nathalie
Weiß, Juliane
Krause-Jüttler, Grit
Weitz, Jürgen
Distler, Marius
Oehme, Florian
von Bechtolsheim, Felix https://orcid.org/0000-0003-2180-7981
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (390696704, 390696704, 390696704, 390696704)
Bundesministerium für Bildung und Forschung (054-2023, 054-2023, 054-2023, 054-2023, 054-2023)
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
- License Information
-
More Information
Article History
Received: 7 August 2024
Accepted: 2 January 2025
First Online: 30 January 2025
Declarations
:
: Karl-Friedrich Kowalewski consulted for Bayer AG, Jansen-Cilag GmgH and Pfizer Inc and gave a presentation for MEDAC GmbH. Jean-Paul Bereuter, Mark Enrik Geissler, Rona Geissler, Felix von Bechtolsheim, Sophia Schmidt, Nathalie Buck, Juliane Weiß, Jürgen Weitz, Florian Oehme and Marius Distler have no conflicts of interest or financial ties to disclosure.
